Showing results (1-10 of 423) with videos related to

Sort By:
Pageof 43
Breast (Edinburgh, Scotland)|January 21, 2004
Pregnancy in a breast cancer patient treated with a LHRH analogue at ablative dosesA M Jiménez-Gordo, E Espinosa, P Zamora, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1995
Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancerE Espinosa, J Feliu, P Zamora, et al.
Anticancer Research|May 1, 1993
Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposalM González Barón, J Feliu, A Ordoñez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ Cooperative GroupM González-Barón, J Feliu, E Espinosa, et al.
American Journal of Clinical Oncology|April 25, 2001
Renal tolerance to cisplatin in patients 70 years and olderA Cubillo, M Cornide, J L López, et al.
American Journal of Clinical Oncology|April 1, 1996
Cisplatin and UFT modulated with leucovorin for the treatment of Advanced non-small-cell lung cancerJ Feliu, M Gonzalez-Baron, E Espinosa, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancerJ Feliu, A Artal, M González Barón, et al.
Oncology (Williston Park, N.Y.)|February 12, 1998
The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative GroupM González Barón, E Espinosa, J Feliu, et al.
Cancer|July 15, 1996
Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative GroupJ Feliu, M González Barón, C García-Girón, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1996
Doctors also suffer when giving bad news to cancer patientsE Espinosa, M González Barón, P Zamora, et al.
Pageof 43